CTSC

(redirected from cathepsin)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Related to cathepsin: Cathepsin C
AcronymDefinition
CTSCClinical and Translational Science Center (University of California at Davis)
CTSCCathepsin
CTSCChenega Technology Services Corporation
CTSCCanadian Technical Security Conference (Burlington, ON, Canada)
CTSCCommunity Treatment and Services Center
CTSCComputerized Test of Self-Control
CTSCClustered Tunnel Server Configuration
CTSCCountrywide Tax Service Corporation
CTSCCarlton Trail Ski Club (Canada)
References in periodicals archive ?
We recently published evidence that high serum concentrations of the cysteine proteases cathepsins B and H are of prognostic importance in predicting the rate of death in colorectal (6) and melanoma cancer (7).
Cathepsin S is a member of the cysteine protease family of cathepsin inhibitors that catalyzes proteolytic cleavage of membrane-bound fractalkine from the surface of neurons to release soluble fractalkine.
Abstract # 1030; Oral Session 05: New Approaches to Osteoporosis Treatment (Preclinical), September 17, 2011, 10:45 - 11:00 AM PT - Efficacy of the combination regimens of the cathepsin K inhibitor odanacatib versus alendronate with parathyroid hormone in estrogen-deficient rabbits
VBY-825 is a member of a series of highly potent, spectrum-selective cathepsin inhibitors with structural diversity, which is being developed by Virobay.
Cathepsins are well known biomarkers in a range of diseases, including atherosclerosis, oncology, pulmonary pathologies, and arthritis.
The second imaging agent to be profiled at the AACR Annual Meeting, Cat B 750 FAST, utilizes VisEn's FAST activatable agent platform to target Cathepsin (Cat) B, a lysosomal cysteine protease highly over-expressed in cancers and premalignant lesions and associated with cancer growth, neo-vascularization and metastasis.
Other secondary endpoints included change from baseline in biochemical markers of bone resorption (s-CTX, u-NTx, u-DPyr), bone formation (s-BSAP, s-P1NP), other markers of osteoclast number (s-TRAP-5b) and cathepsin K activity (s-1CTP).
a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat-K FAST(TM) imaging agent for measuring and monitoring Cathepsin K activity associated with disease progression and therapeutic response in vivo.
This molecule is a cathepsin K inhibitor, designed to treat skeletal disorders such as osteoporosis and osteoarthritis.
Doing this the researchers were able to detect fibrin - a protein that causes clots to form, and cathepsin B, an enzyme found in the most dangerous plaques.
A sampling of topics includes BMP signaling and skeletogenesis; the regulation of cathepsin K gene expression; and bone destruction in multiple myeloma.